Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review
X Zou, XY Tang, ZY Qu, ZW Sun, CF Ji, YJ Li… - International Journal of …, 2022 - Elsevier
Platelet-derived growth factors (PDGFs) and PDGF receptors (PDGFRs) are expressed in a
variety of tumors. Activation of the PDGF/PDGFR signaling pathway is associated with …
variety of tumors. Activation of the PDGF/PDGFR signaling pathway is associated with …
[HTML][HTML] 血小板衍生生长因子BB 在川崎病血小板增多中的作用及机制研究
沈西伟， 汤志远， 申娴娟， 赵建美 - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
血小板衍生生长因子BB在川崎病血小板增多中的作用及机制研究- PMC Back to Top Skip to main
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
Ex vivo platelet morphology assessment of chronic myeloid leukemia patients before and after Imatinib treatment
L Repsold, R Pool, M Karodia… - Microscopy …, 2022 - Wiley Online Library
Chronic myeloid leukemia (CML) is a myeloproliferative disease and the first line treatment
is through the administration of Imatinib, a first generation tyrosine kinase inhibitor …
is through the administration of Imatinib, a first generation tyrosine kinase inhibitor …
Role and mechanism of platelet-derived growth factor BB in thrombocytosis in Kawasaki disease
XW Shen, ZY Tang, XJ Shen… - … Dang dai er ke za zhi …, 2023 - europepmc.org
Objectives To study the role and mechanism of platelet-derived growth factor BB (PDGF-BB)
on platelet production in Kawasaki disease (KD) mice and human megakaryocytic Dami …
on platelet production in Kawasaki disease (KD) mice and human megakaryocytic Dami …
Successful treatment of a chronic myeloid leukemia patient with extreme thrombocytosis by a combination of imatinib and interferon‑α: A case report
MX Jia, DL Di, ZZ Liu, HY Wang… - Experimental and …, 2025 - spandidos-publications.com
Chronic myeloid leukemia with extreme thrombocytosis (CML‑T), defined by a platelet
count> 1,000 x10 9/l is a rare leukemia subtype. The present case report described a 66 …
count> 1,000 x10 9/l is a rare leukemia subtype. The present case report described a 66 …